Status:
RECRUITING
A Game-based Neurodevelopmental Assessment for Young Children
Lead Sponsor:
Brightlobe Limited
Conditions:
Neurodevelopmental Disorders
Autism Spectrum Disorder
Eligibility:
All Genders
3-8 years
Brief Summary
The aim of this study is to evaluate a novel tablet game-based neurodevelopmental assessment tool for young children aged 3 to 8 years old. The study's main aims are: (1) to determine whether the nov...
Eligibility Criteria
Inclusion Criteria:
- 3 to 8 year old 'typically' developing children with no known neurodevelopmental disorder.
OR
- 3 to 8 year old children with a diagnosed neurodevelopmental disorder, including Attention Deficit Hyperactivity Disorder (ADHD), Autism Spectrum Disorder (ASD), Specific Learning Disorder, or a Communication Disorder.
All parents/caregivers and children must have a minimum level of English fluency required to complete the parent questionnaire and the game-based assessment.
Exclusion Criteria:
- Children with medical comorbidities, a chronic illness or any additional diagnoses that would impact their ability to complete the game-based assessment.
Key Trial Info
Start Date :
January 30 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2026
Estimated Enrollment :
590 Patients enrolled
Trial Details
Trial ID
NCT05780853
Start Date
January 30 2023
End Date
June 30 2026
Last Update
July 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Brightlobe Limited
London, United Kingdom